GroundRules
Browse Federal regulations
Read the original sections, or search by topic.
- 21 CFR 349.14 · Ophthalmic emollients.
- 21 CFR 349.16 · Ophthalmic hypertonicity agent.
- 21 CFR 349.18 · Ophthalmic vasoconstrictors.
- 21 CFR 349.20 · Eyewashes.
- 21 CFR 349.30 · Permitted combinations of active ingredients.
- 21 CFR 349.50 · Labeling of ophthalmic drug products.
- 21 CFR 349.55 · Labeling of ophthalmic astringent drug products.
- 21 CFR 349.60 · Labeling of ophthalmic demulcent drug products.
- 21 CFR 349.65 · Labeling of ophthalmic emollient drug products.
- 21 CFR 349.70 · Labeling of ophthalmic hypertonicity drug products.
- 21 CFR 349.75 · Labeling of ophthalmic vasoconstrictor drug products.
- 21 CFR 349.78 · Labeling of eyewash drug products.
- 21 CFR 349.79 · Labeling of permitted combinations of active ingredients.
- 21 CFR 349.80 · Professional labeling.
- 21 CFR 350.1 · Scope.
- 21 CFR 350.3 · Definition.
- 21 CFR 350.10 · Antiperspirant active ingredients.
- 21 CFR 350.50 · Labeling of antiperspirant drug products.
- 21 CFR 350.60 · Guidelines for effectiveness testing of antiperspirant drug products.
- 21 CFR 352.1 · Scope.
- 21 CFR 352.3 · Definitions.
- 21 CFR 352.10 · Sunscreen active ingredients.
- 21 CFR 352.20 · Permitted combinations of active ingredients.
- 21 CFR 352.50 · Principal display panel of all sunscreen drug products.
- 21 CFR 352.52 · Labeling of sunscreen drug products.
- 21 CFR 352.60 · Labeling of permitted combinations of active ingredients.
- 21 CFR 352.70 · Standard sunscreen.
- 21 CFR 352.71 · Light source (solar simulator).
- 21 CFR 352.72 · General testing procedures.
- 21 CFR 352.73 · Determination of SPF value.
- 21 CFR 352.76 · Determination if a product is water resistant or very water resistant.
- 21 CFR 352.77 · Test modifications.
- 21 CFR 355.1 · Scope.
- 21 CFR 355.3 · Definitions.
- 21 CFR 355.10 · Anticaries active ingredients.
- 21 CFR 355.20 · Packaging conditions.
- 21 CFR 355.50 · Labeling of anticaries drug products.
- 21 CFR 355.55 · Principal display panel of all fluoride rinse drug products.
- 21 CFR 355.60 · Professional labeling.
- 21 CFR 355.70 · Testing procedures for fluoride dentifrice drug products.
- 21 CFR 357.101 · Scope.
- 21 CFR 357.103 · Definition.
- 21 CFR 357.110 · Anthelmintic active ingredient.
- 21 CFR 357.150 · Labeling of anthelmintic drug products.
- 21 CFR 357.152 · Package inserts for anthelmintic drug products.
- 21 CFR 357.180 · Professional labeling.
- 21 CFR 357.201 · Scope.
- 21 CFR 357.203 · Definition.
- 21 CFR 357.210 · Cholecystokinetic active ingredients.
- 21 CFR 357.250 · Labeling of cholecystokinetic drug products.
- 21 CFR 357.280 · Professional labeling.
- 21 CFR 357.801 · Scope.
- 21 CFR 357.803 · Definitions.
- 21 CFR 357.810 · Active ingredients for deodorant drug products for internal use.
- 21 CFR 357.850 · Labeling of deodorant drug products for internal use.
- 21 CFR 358.101 · Scope.
- 21 CFR 358.103 · Definitions.
- 21 CFR 358.110 · Wart remover active ingredients.
- 21 CFR 358.150 · Labeling of wart remover drug products.
- 21 CFR 358.301 · Scope.
- 21 CFR 358.303 · Definitions.
- 21 CFR 358.310 · Ingrown toenail relief active ingredient.
- 21 CFR 358.350 · Labeling of ingrown toenail relief drug products.
- 21 CFR 358.501 · Scope.
- 21 CFR 358.503 · Definitions.
- 21 CFR 358.510 · Corn and callus remover active ingredients.
- 21 CFR 358.550 · Labeling of corn and callus remover drug products.
- 21 CFR 358.601 · Scope.
- 21 CFR 358.603 · Definition.
- 21 CFR 358.610 · Pediculicide active ingredients.
- 21 CFR 358.650 · Labeling of pediculicide drug products.
- 21 CFR 358.701 · Scope.
- 21 CFR 358.703 · Definitions.
- 21 CFR 358.710 · Active ingredients for the control of dandruff, seborrheic dermatitis, or psoriasis.
- 21 CFR 358.720 · Permitted combinations of active ingredients.
- 21 CFR 358.750 · Labeling of drug products for the control of dandruff, seborrheic dermatitis, or psoriasis.
- 21 CFR 358.760 · Labeling of permitted combinations of active ingredients for the control of dandruff.
- 21 CFR 361.1 · Radioactive drugs for certain research uses.
- 21 CFR 369.1 · Purpose of issuance.
- 21 CFR 369.2 · Definitions.
- 21 CFR 369.3 · Warnings required on drugs exempted from prescription-dispensing requirements of section 503(b)(1)(C).
- 21 CFR 369.4 · Warnings suggested for drugs by formal or informal statements of policy.
- 21 CFR 369.6 · [Reserved]
- 21 CFR 369.7 · Warnings required by official compendia.
- 21 CFR 369.8 · Warning statements in relation to conditions for use.
- 21 CFR 369.9 · General warnings re accidental ingestion by children.
- 21 CFR 369.10 · Conspicuousness of warning statements.
- 21 CFR 369.20 · Drugs; recommended warning and caution statements.
- 21 CFR 369.21 · Drugs; warning and caution statements required by regulations.
- 21 CFR 500.23 · Thermally processed low-acid foods packaged in hermetically sealed containers.
- 21 CFR 500.24 · Emergency permit control.
- 21 CFR 500.25 · Anthelmintic drugs for use in animals.
- 21 CFR 500.26 · Timed-release dosage form drugs.
- 21 CFR 500.27 · Methylene blue-containing drugs for use in animals.
- 21 CFR 500.29 · Gentian violet for use in animal feed.
- 21 CFR 500.30 · Gentian violet for animal drug use.
- 21 CFR 500.45 · Use of polychlorinated biphenyls (PCB's) in the production, handling, and storage of animal feed.
- 21 CFR 500.46 · Hexachlorophene in animal drugs.
- 21 CFR 500.50 · Propylene glycol in or on cat food.
- 21 CFR 500.51 · Labeling of animal drugs; misbranding.